DS
Deepak Soomnath Bhat
About Deepak Soomnath Bhat
Data last updated:
Deepak Soomnath Bhat has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Denzai Innovations & Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Denzai Innovations & Therapeutics Private Limited at ₹3.89 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Denzai Innovations & Therapeutics Private Limited U74999GJ2016PTC091894 | Director | 10 May 2016 | 2016 | ₹3.89 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Deepak Soomnath Bhat
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepak Soomnath Bhat
Deepak Soomnath Bhat has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Denzai Innovations & Therapeutics Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Denzai Innovations & Therapeutics Private Limited at ₹3.89 Cr (FY 2025).
Deepak Soomnath Bhat is associated with 1 company as Director, including Denzai Innovations & Therapeutics Private Limited (₹3.89 Cr).
Deepak Soomnath Bhat has expertise in General Business.
Deepak Soomnath Bhat has 10 years in corporate governance.
By reported revenue, the largest current company of Deepak Soomnath Bhat is Denzai Innovations & Therapeutics Private Limited, with revenue of ₹3.89 Cr (FY 2025).
Deepak Soomnath Bhat currently holds positions at 1 company: Denzai Innovations & Therapeutics Private Limited (₹3.89 Cr).